Author details
Author Frank Hulstaert
Comment :
"More about author"
|
Available item(s) by this author (132)
Add the result to your basket Make a suggestion Refine your search Apply to external sources
Age-related changes in human blood lymphocyte subpopulations / F. Erkeller-Yuksel in The Journal of Pediatrics, 120(1996)2 ([02/01/1996])
[article] Age-related changes in human blood lymphocyte subpopulations [printed text] / F. Erkeller-Yuksel, Author ; V. Deneys, Author ; B. Yuksel, Author ; I. Hannet, Author ; Frank Hulstaert, Author ; C. Hamilton, Author . - 1996 . - 216-222.
Languages : English (eng)
in The Journal of Pediatrics > 120(1996)2 [02/01/1996] . - 216-222
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Adolescent ; Adult ; Aged ; Aging ; Antigens, CD ; Child ; Child, Preschool ; Female ; Fetal Blood ; Humans ; Immunophenotyping ; Infant ; Journal Article ; Leukocyte Count ; Lymphocyte Subsets ; Male ; Middle Aged ; Peer Review ; United StatesAbstract: Flow cytometric analysis of major lymphocyte populations and their subsets reveals age-related changes in the cellular human immune system. Immunophenotypic markers were evaluated in 110 normal pediatric subjects, divided into groups of newborn infants, infants aged 2 days to 11 months, and children aged 1 to 6 years and 7 to 17 years; results were then compared with those obtained from 101 normal adults aged 18 to 70 years. Comparisons among age groups from newborn infants through adults reveal progressive declines in the absolute numbers of leukocytes, total lymphocytes, and T, B, and natural killer (NK) cells. The percentages of T cells within the total lymphocyte population increase with age, in both CD4+ and CD8+ subsets. Percentages of B and NK cells are higher in newborn infants than in adults. The expression of the activation markers interleukin-2R and HLA-DR on T cells increases with age, as does the NK-associated expression of CD57 on CD8 cells. The proportions of B lymphocytes that coexpress CD5 or CDw78 decrease with age, whereas expression of Leu-8 and CD23 increases. The proportion of CD4 cells bearing the CD45RA and Leu-8 markers is consistently lower in adults than in children. These data may serve as a reference range for studies of pediatric subjects. Link for e-copy: http://www.sciencedirect.com/science/journal/00223476 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2187 [article]Age-related changes in human blood lymphocyte subpopulations / Frank Hulstaert in Clinical immunology and immunopathology, 70(1994)02 ([02/01/1994])
[article] Age-related changes in human blood lymphocyte subpopulations : II. Varying Kinetics of Percentage and Absolute Count Measurements [printed text] / Frank Hulstaert, Author ; I. Hannet, Author ; V. Deneys, Author ; V. Munhyeshuli, Author ; T. Reichert, Author ; M. De Bruyere, Author ; K. Strauss, Author . - 1994 . - 152-158.
Languages : English (eng)
in Clinical immunology and immunopathology > 70(1994)02 [02/01/1994] . - 152-158
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Adolescent ; Adult ; Aging ; Antigens, CD ; Antigens, Differentiation ; Child ; Child, Preschool ; Female ; Humans ; Immunophenotyping ; Infant ; Infant, Newborn ; Journal Article ; Leukocyte Count ; Male ; Middle Aged ; T-Lymphocytes ; United StatesAbstract: A reference range for lymphocyte populations, with particular emphasis on T lymphocyte subsets, was obtained for normal individuals covering age cohorts from birth through adulthood. This report confirms and extends findings from a developmental reference range published earlier (1). Absolute numbers of WBC, lymphocytes, and T, B, and NK subsets decline significantly during childhood. However, differences in the rate of decline of certain lymphocyte subsets leads to discordance between absolute numbers and percentages. Those lymphocyte subsets which decline less rapidly with age than the total lymphocyte count will show an increase in percentage, whereas those which decline more rapidly will show further declines in percentage values. T cell percentages were seen to increase over time whereas B cell percentages decline. Markers of immaturity such as CD45RA on CD4 cells and CD38 on CD8 cells declined in both percentages and absolute numbers. Activation markers, such as HLA-DR on CD8 cells and IL2-R on CD3 cells, increased in percentages with time but changed inconsistently in cell number from infancy to adulthood. These findings extend the lymphocyte references range to markers thought to be informative in various disease states, including HIV infection. Link for e-copy: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WCK-45R79S2-9&_user=1 [...] Format of e-copy: VDIC IP recognition Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2209 [article]An optimized method for routine HLA-B27 screening using flow cytometry / Frank Hulstaert in Cytometry, 18(1994)1 ([03/15/1994])
[article] An optimized method for routine HLA-B27 screening using flow cytometry [printed text] / Frank Hulstaert, Author ; Johan Albrecht, Author ; I. Hannet, Author ; P. Lancaster, Author ; L. Buchner, Author ; J. Kunz, Author ; A. Falkenrodt, Author ; M. Tongio, Author ; F. De Keyser, Author ; E.M. Veys, Author . - 1994 . - 21-29.
Languages : English (eng)
in Cytometry > 18(1994)1 [03/15/1994] . - 21-29
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Anticoagulants ; Blood Donors ; Blood Preservation ; Cytotoxicity Tests, Immunologic ; Evaluation Studies as Topic ; Flow Cytometry ; Great Britain ; Humans ; Immune Sera ; Journal Article ; Mass Screening ; Peer Review ; Reproducibility of Results ; Sensitivity and specificityAbstract: Flow cytometry and monoclonal antibodies are promising tools for HLA-antigen detection. Previous approaches have been hampered by the lack of a carefully standardized system for calibration and sample analysis. A new system for HLA-B27 screening was developed using a FACScan flow cytometer, software for automated calibration and analysis, calibration beads, and the anti-HLA-B27-FITC/anti-Leu4-PE (CD3) monoclonal antibodies. The median fluorescence channel result for the HLA-B27-FITC signal of CD3+ T lymphocytes is compared to a decision marker. Values lower than this threshold are read as HLA-B27 negative and those above are recommended for retesting with the classic microcytotoxicity assay on the presumption of HLA-B27 positivity. The anti-HLA-B27 antibody reacts with all six HLA-B27 subtypes and shows a weaker binding to HLA-B7. The screening test results were compared with those from the microcytotoxicity assay for HLA-typing in studies involving several European centers. The observed sensitivity was 100% (95% Cl:98.6-100) and the specificity was 97.4% (95% Cl: 96.4-98.3). Other performance studies verified the reproducibility and reliability of results obtained with the screening system. Link for e-copy: http://onlinelibrary.wiley.com/doi/10.1002/cyto.990180106/pdf Format of e-copy: PDF [Open Access] (Embargo 1 years) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2211 [article]Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. / H. Vanderstichele in Clinical chemistry and laboratory medicine, 44(2006)12 ([01/01/2006])
[article] Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. [printed text] / H. Vanderstichele, Author ; K. De Vreese, Author ; K. Blennow, Author ; N. Andreasen, Author ; C. Sindic, Author ; A. Ivanoiu, Author ; H. Hampel, Author ; K. Burger, Author ; L. Parnetti, Author ; A. Padovani, Author ; M. Di Luca, Author ; M. Blaser, Author ; A.O. Olsson, Author ; H. Pottel, Author ; Frank Hulstaert, Author ; E. Vanmechelen, Author . - 2006.
Languages : English (eng)
in Clinical chemistry and laboratory medicine > 44(2006)12 [01/01/2006]
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Aged ; Alzheimer Disease ; Amyloid beta-Peptides ; Biological Markers ; Diagnosis, Differential ; Discriminant Analysis ; Enzyme-Linked Immunosorbent Assay ; Female ; Germany ; Humans ; Journal Article ; Lewy Body Disease ; Logistic Models ; Male ; Middle Aged ; Peer Review ; Peptide Fragments ; Reproducibility of Results ; Sensitivity and specificityAbstract: BACKGROUND: Total tau (T-tau) and beta-amyloid((1-42)) (Abeta(1-42)) levels in cerebrospinal fluid (CSF) can differentiate Alzheimer's disease (AD) from normal aging or depressive pseudo-dementia. Differential diagnosis from dementia with Lewy bodies (DLB) in clinical settings is difficult.
METHODS: The analytical performance of the INNOTEST PHOSPHO-TAU(181P) assay was validated in terms of selectivity, sensitivity, specificity, precision, robustness, and stability. Clinical utility of the assay alone, or combined with T-tau and Abeta(1-42), for discrimination of AD (n=94) from patients suffering from DLB (n=60) or from age-matched control subjects (CS) (n=60) was assessed in a multicenter study.
RESULTS: CSF concentrations of tau phosphorylated at threonine 181 (P-tau(181P)) in AD was significantly higher than in DLB and CS. Discriminant analysis, a classification tree, and logistic regression showed that P-tau(181P) was the most statistically significant single variable of the three biomarkers for discrimination between AD and DLB.
CONCLUSIONS: P-tau(181P) quantification is a robust and reliable assay that may be useful in discriminating AD from DLB.Link for e-copy: http://dx.doi.org/10.1515/CCLM.2006.258 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2205 [article]Antiviral agents in seasonal and pandemic influenza / N Van de Vyver ; W Janssens ; An De Sutter ; B Michiels ; Frans Govaerts ; Frank Hulstaert ; Marie-Laurence Lambert ; R Peleman ; Dirk Ramaekers / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
Antiviral agents in seasonal and pandemic influenza : Literature study and development of practice guidelines [printed text] / N Van de Vyver, Author ; W Janssens, Author ; An De Sutter, Author ; B Michiels, Author ; Frans Govaerts, Author ; Frank Hulstaert, Author ; Marie-Laurence Lambert, Author ; R Peleman, Author ; Dirk Ramaekers, Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2006 . - Viii, 158 p. : ill. ; 30 cm.. - (KCE Reports. Good Clinical Practice (GCP); 49C) .
0 €
Study no. 2006-27-1
Languages : English (eng)
Descriptors: Classification
QV 268.5 Antiviral agents
Indexation
2006-27-1 ; Enzyme Inhibitors ; Influenza A Virus, H5N1 Subtype ; Influenza, Human ; R49Link for e-copy: https://doi.org/10.57598/R49C Format of e-copy: .PDF (927 KB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1636 Copies(0)
Status No copy Antivirale middelen bij seizoensgriep en grieppandemie. / N Van de Vyver ; W Janssens ; An De Sutter ; B Michiels ; Frans Govaerts ; Frank Hulstaert ; Marie-Laurence Lambert ; R Peleman ; Dirk Ramaekers / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkAre biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? / Maria-Isabel Farfan-Portet in European Journal of Health Economics (The), 15(2014)3 ([04/01/2014])
PermalinkBaarmoederhalskankerscreening en testen op Human Papillomavirus (HPV) / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkBarrières en drijfveren voor de opname van biosimilaire geneesmiddelen in België / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkBarriers and opportunities for the uptake of biosimilar medicines in Belgium / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkBarriers and opportunities for the uptake of biosimilar medicines in Belgium / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkBenefits and costs of innovative oncology drugs in Belgium (2004-2017) / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkBenefits and costs of innovative oncology drugs in Belgium / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkCancer du poumon à petites cellules et non à petites cellules / Isabelle Wauters / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkCancer screening: EU recommendations and current practice in Belgium / Mattias Neyt in Archives of Public Health, 66(2008)3 ([09/01/2009])
PermalinkA candidate vaccine based on the hepatitis C E1 protein / Leroux-Roels, G in Vaccine, 22(2004)23-24 ([08/13/2004])
PermalinkCapsule endoscopie / Johan Poelmans / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkCervical Cancer Screening and Human Papillomavirus (HPV) Testing / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkContingent non-invasive prenatal testing / Wilfried Gyselaers in Prenatal Diagnosis, 35(2015)13 ([12/01/2015])
PermalinkCost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium / Yvres Horsmans / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2010)
PermalinkCost-effectiveness of human papillomavirus vaccination in Belgium / Nancy Thiry in International Journal of Technology Assessment in Health Care, 25(2009)2 ([04/01/2009])
PermalinkCritical assessment of Belgian reimbursement dossiers of orphan drugs / Alain Denis in Value in Health, 13(2010)7 ([11/01/2010])
PermalinkDépistage du cancer du col de l’utérus et recherche du Papillomavirus humain (HPV) / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkDistribution and composition of HDL subclasses in students whose parents suffered prematurely from a myocardial infarction in comparison with controls / M. Rosseneu in Atherosclerosis, 63(1987)2-3 ([02/01/1987])
PermalinkDo innovative medicines against cancer always have a real added value? / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
Permalink[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium] / Christoph Schwierz / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
PermalinkEconomic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkEconomische evaluatie van antivirale behandeling van chronische hepatitis B in België / Christoph Schwierz / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
PermalinkEndoscopie par capsule / Johan Poelmans / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkEvaluation clinique des dispositifs médicaux innovants à haut risque avant leur mise sur le marché / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
PermalinkEvaluation économique du traitement antiviral de l’hépatite B chronique en Belgique / Christoph Schwierz / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
PermalinkEvidence gaps for drugs and medical devices at market entry in Europe and potential solutions / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkEvidence gaps for drugs and medical devices at market entry in Europe and potential solutions / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkExpression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection / L. Kestens in AIDS, 6(1992)8 ([08/01/1992])
PermalinkExtremiteiten MRI / Marijke Eyssen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkExtremity-only MRI / Marijke Eyssen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkExtremity-only MRI / Marijke Eyssen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkExtremity-only MRI / Marijke Eyssen / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkFinancer des essais cliniques axés sur la pratique avec des fonds publics / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkFlow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease / M. Senju in Gut, 32(1991)7 ([07/01/1991])
PermalinkFreins et leviers à l’adoption des médicaments biosimilaires en Belgique / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkFunnel plots should become the standard methodology to identify centres deserving further scrutiny / France Vrijens in Journal of Hospital Infection, 74(2010)04 ([04/01/2010])
PermalinkFuture scenarios about drug development and drug pricing / Philippe Vandenbroeck / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkFuture scenarios about drug development and drug pricing / Philippe Vandenbroeck / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkHadron therapie bij kinderen / Roos Leroy / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkHadron therapy in children / Roos Leroy / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkHadron therapy in children / Roos Leroy / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkHadron therapy in children / Roos Leroy / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkHadronthérapie chez l’enfant / Roos Leroy / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkHebben innovatieve geneesmiddelen tegen kanker altijd een echte meerwaarde? / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkHépatite C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkHépatite C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
Permalink[Hepatitis C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkHepatitis C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkHepatitis C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkHepatitis C / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
PermalinkHospital-acquired, laboratory-confirmed bloodstream infections / France Vrijens in Journal of Hospital Infection, 75(2010)03 ([04/01/2010])
PermalinkHow many CIN2+ lesions can be avoided through HPV 16/18 vaccination? / Frank Hulstaert in Acta obstetricia et gynecologica Scandinavica, 88(2009)07 ([07/01/2009])
PermalinkHPV Vaccinatie ter Preventie van Baarmoederhalskanker in België. HTA / Nancy Thiry ; Marie-Laurence Lambert ; Irina Cleemput ; Huybrechts, Michel ; Mattias Neyt ; Frank Hulstaert ; Chris De Laet / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2007)
PermalinkHPV Vaccination for the Prevention of Cervical Cancer in Belgium: HTA / Nancy Thiry ; Marie-Laurence Lambert ; Irina Cleemput ; Huybrechts, Michel ; Mattias Neyt ; Frank Hulstaert ; Chris De Laet / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2007)
PermalinkHTA Diagnostic moléculaire en Belgique. / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2005)
PermalinkHTA Diagnostic moléculaire en Belgique / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2005)
PermalinkHTA Moleculaire Diagnostiek in België / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2005)
PermalinkLes infections nosocomiales en Belgique, volet 1 / France Vrijens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2008)
PermalinkLes infections nosocomiales en Belgique (volet II) / France Vrijens ; Frank Hulstaert ; Bart Gordts ; Chris De Laet ; Stephan Devriese ; Stefaan Van de Sande ; Huybrechts, Michel ; Gert Peeters / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkInnovatieve radiotherapie-technieken / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkInnovative radiotherapy techniques / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkInnovative radiotherapy techniques / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkIntensiteitsgemoduleerde Radiotherapie (IMRT) / Van den Steen, Dirk / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2007)
PermalinkIntensity-modulated radiotherapy (IMRT) / Van den Steen, Dirk / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2007)
PermalinkInterventions pharmaceutiques et non pharmaceutiques dans la maladie d’Alzheimer : une évaluation rapide / Nancy Thiry / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkIntroducing the non-invasive prenatal test for trisomy 21 in Belgium / Mattias Neyt in BMJ open, 4(2014)11 ([11/07/2014])
PermalinkIntroduction of high-risk medical devices / Mattias Neyt in Expert Review of Medical Devices, 14(2017)01 ([01/27/2017])
PermalinkKleincellige en Niet-Kleincellige Longkanker / Isabelle Wauters / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkDe klinische evaluatie vóór markttoegang van innovatieve hoogrisico medische hulpmiddelen / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
PermalinkKosteneffectiviteit van antivirale behandeling voor chronische hepatitis B in België / Yvres Horsmans / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2010)
PermalinkMammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer / Lorena San Miguel / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2018)
PermalinkMarket introduction of innovative high risk medical devices / Imgard Vinck in European Journal of Health Law, 18(2011)05 ([12/01/2011])
PermalinkMarkttoegang in Europa voor geneesmiddelen en medische hulpmiddelen: gebrek aan bewijs en mogelijke oplossingen / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkMedicamenteuze en niet-medicamenteuze interventies voor de ziekte van Alzheimer, een rapid assessment / Nancy Thiry / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkMédicaments antiviraux en cas de grippe saisonnière et pandémique / N Van de Vyver ; W Janssens ; An De Sutter ; B Michiels ; Frans Govaerts ; Frank Hulstaert ; Marie-Laurence Lambert ; R Peleman ; Dirk Ramaekers / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2006)
PermalinkLes médicaments innovants contre le cancer ont-ils toujours une réelle valeur ajoutée ? / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkMise sur le marché européen des dispositifs médicaux innovants à haut risque : l’efficacité clinique et la sécurité sont-elles garanties ? / Sabine Stordeur in Revue d'Epidémiologie et de Santé Publique, 61(2013)02 ([04/01/2013])
PermalinkMise sur le marché des médicaments et des dispositifs médicaux en Europe : manque de données probantes et solutions possibles / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
PermalinkMoleculaire Diagnostiek in België. / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2005)
PermalinkNaar een gecontroleerde en gefaseerde introductie van hoogrisico medische hulpmiddelen in België / Hanne Baeyens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkNaar een uitbreiding van de terugbetaling van de hepatitis c-behandelingen ? / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkNext generation sequencing gen-panels voor gerichte therapie in de oncologie en hemato-oncologie / Marc Van den Bulcke / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkNext generation sequencing gene panels for targeted therapy in oncology and haemato-oncology / Marc Van den Bulcke / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkNext generation sequencing gene panels for targeted therapy in oncology and haemato-oncology / Marc Van den Bulcke / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkDe niet-invasieve prenatale test (NIPT) voor trisomie 21 / Frank Hulstaert / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2014)
PermalinkNosocomial Infections in Belgium, part 1 / France Vrijens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2008)
PermalinkNosocomial Infections in Belgium, part 2 / France Vrijens ; Frank Hulstaert ; Bart Gordts ; Chris De Laet ; Stephan Devriese ; Stefaan Van de Sande ; Huybrechts, Michel ; Gert Peeters / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkNosocomiale infecties in België, deel 1 / France Vrijens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2008)
PermalinkNosocomiale Infecties in België (deel II) / France Vrijens ; Frank Hulstaert ; Bart Gordts ; Chris De Laet ; Stephan Devriese ; Stefaan Van de Sande ; Huybrechts, Michel ; Gert Peeters / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkOncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome / Jo Robays / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkOncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome / Jo Robays / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkOncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2 / Jo Robays / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkOncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2 / Jo Robays / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
PermalinkOncogenetische testen, diagnostiek en opvolging bij het syndroom van Birt-Hogg-Dubé, het FAMMM-syndroom en neurofibromatose type 1 en 2 / Jo Robays / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
Permalink